Reumavid is a questionnaire investigating the consequences of the covid-19 pandemic on people living with rheumatic conditions in United Kingdom.
The survey is aimed at people living with rheumatic diseases who are experiencing confinement due to COVID-19.
Its aim is to describe the consequences of the pandemic on the evolution of the disease, support services, healthcare, the quality of life and the emotional well-being of people living with rheumatic diseases.
This study is promoted by National Axial Spondyloarthritis Society (NASS), National Rheumatoid Arthritis Society (NRAS), and Arthritis Action, and conducted by the Health & Territory Research (HTR) of the University of Seville, with the support of Novartis Pharma AG.…
Read more of this article
New information on preventing musculoskeletal
Suggestions are rolling in for which changes the NHS has made during the pandemic that people think we should keep.
Pain UK would like to alert you to the work of the Covid-19 Global Rheumatology Alliance, an organisation established to “collect, analyze and disseminate information about COVID-19 and rheumatology to patients, physicians and other relevant groups to improve the care of patients with rheumatic disease.”
Arthritis Action invites you to a webinar dedicated to addressing coronavirus concerns for people with arthritis.
Right Start
ARMA holds its first ever multi-disciplinary MSK health conference – Working Together to change the face of MSK.
NRAS is adapting to these challenging times and has been hosting live broadcasts via Facebook Live and webinars since the beginning of this crisis. You can watch any of the recorded sessions again on the
